Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
3.420
+0.110 (3.32%)
At close: Sep 3, 2025, 4:00 PM
3.390
-0.030 (-0.87%)
After-hours: Sep 3, 2025, 6:29 PM EDT
Savara Market Cap
Savara has a market cap or net worth of $720.56 million as of September 3, 2025. Its market cap has decreased by -2.93% in one year.
Market Cap
720.56M
Enterprise Value
603.42M
1-Year Change
-2.93%
Ranking
Category
Stock Price
$3.42
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $720.56M, an increase of 443.00%. That is a compound annual growth rate of 22.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 572.10M | 8.58% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
| Apr 28, 2017 | 132.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.90B |
| Johnson & Johnson | 427.22B |
| AbbVie | 375.34B |
| UnitedHealth Group | 275.45B |
| Novo Nordisk | 248.91B |
| AstraZeneca | 247.16B |
| Novartis AG | 244.04B |
| Abbott Laboratories | 227.48B |